FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987524194> ?p ?o ?g. }

• W2987524194 endingPage "152733" @default.
• W2987524194 startingPage "152733" @default.
• W2987524194 abstract "LINC00261 plays a vital role in tumorigenesis and metastasis of digestive system cancer. However, an influence of LINC00261 on cholangiocarcinoma has a little research. There, we investigated clinical role and molecular mechanisms of LINC00261 in cholangiocarcinoma.The qRT-PCR was performed for the detection of LINC00261 level in 50 paired specimens from CCA patients and six cell lines. Cell proliferation were explored by CCK-8 and colony formation assays in QBC939 and RBE cells after transfected with si-LINC00261 or si-NC. Then, AO/EB double fluorescence staining and flow cytometric assays were performed to assess cell apoptosis. Transwell and wound healing assays were selected to evaluate migratory and invasive property of cells. Protein levels, such as PCNA, Bax, Bcl-2, and several epithelial-to-mesenchymal transition markers, including E-cadherin, N-cadherin and Vimentin, were detected by western blot assays. Furthermore, we use a R2 platform to evaluate the correlation between LINC00261 and EMT makers and predict the overall survival and relapse-free survival for CCA patients by the expression of LINC00261/ EMT makers.LINC00261 was overexpressed in cancerous tissues and CCA cell lines compared with adjacent tissues and HIBEC, respectively. Up-regulation of LINC00261 was related to larger tumor size (p = 0.009), positive lymph node metastasis (p = 0.021), advanced TNM stages (p = 0.017) and higher postoperative recurrence (p = 0.009) for CCA patients. Additionally, univariate and multivariate analysis displayed that LINC00261 an independent prognostic factor in CCA patients. Knockdown of LINC00261 expression in RBE and QBC939 cell lines inhibited cell proliferation, migration and invasion property and increased cell apoptosis and the EMT progression. Moreover, there was a strong correlation between LINC00261 and E-cadherin (CDH1) (p < 0.05), and low expression of E-cadherin (CDH1) has a poor overall survival and relapse-free survival in CCA patients (p < 0.05).Overall, high level of LINC00261 in CCA predicts a poor prognosis, and promotes a metastasis via EMT process. Thus, LINC00261 could be a promising biomarker and therapeutic target for CCA, and in the high level of LINC00261 in CCA, E-cadherin or CDH1 might be an effective factor for tumor metastasis or poor prognosis." @default.
• W2987524194 created "2019-11-22" @default.
• W2987524194 creator A5030336185 @default.
• W2987524194 creator A5044946212 @default.
• W2987524194 creator A5062868032 @default.
• W2987524194 creator A5064738683 @default.
• W2987524194 creator A5069497923 @default.
• W2987524194 creator A5069915515 @default.
• W2987524194 creator A5071543379 @default.
• W2987524194 creator A5084257557 @default.
• W2987524194 creator A5085649748 @default.
• W2987524194 date "2020-01-01" @default.
• W2987524194 modified "2023-10-01" @default.
• W2987524194 title "Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma" @default.
• W2987524194 cites W1970159832 @default.
• W2987524194 cites W1971183183 @default.
• W2987524194 cites W2001620773 @default.
• W2987524194 cites W2021568852 @default.
• W2987524194 cites W2026262319 @default.
• W2987524194 cites W2036457027 @default.
• W2987524194 cites W2037164633 @default.
• W2987524194 cites W2043191323 @default.
• W2987524194 cites W2070603042 @default.
• W2987524194 cites W2075957912 @default.
• W2987524194 cites W2137957667 @default.
• W2987524194 cites W2141078344 @default.
• W2987524194 cites W2335029242 @default.
• W2987524194 cites W2337288706 @default.
• W2987524194 cites W2412845632 @default.
• W2987524194 cites W2550626506 @default.
• W2987524194 cites W2781338802 @default.
• W2987524194 cites W2786843484 @default.
• W2987524194 cites W2788729882 @default.
• W2987524194 cites W2885187889 @default.
• W2987524194 cites W2897897000 @default.
• W2987524194 cites W2947753036 @default.
• W2987524194 cites W2952837933 @default.
• W2987524194 doi "https://doi.org/10.1016/j.prp.2019.152733" @default.
• W2987524194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31812439" @default.
• W2987524194 hasPublicationYear "2020" @default.
• W2987524194 type Work @default.
• W2987524194 sameAs 2987524194 @default.
• W2987524194 citedByCount "15" @default.
• W2987524194 countsByYear W29875241942020 @default.
• W2987524194 countsByYear W29875241942021 @default.
• W2987524194 countsByYear W29875241942022 @default.
• W2987524194 countsByYear W29875241942023 @default.
• W2987524194 crossrefType "journal-article" @default.
• W2987524194 hasAuthorship W2987524194A5030336185 @default.
• W2987524194 hasAuthorship W2987524194A5044946212 @default.
• W2987524194 hasAuthorship W2987524194A5062868032 @default.
• W2987524194 hasAuthorship W2987524194A5064738683 @default.
• W2987524194 hasAuthorship W2987524194A5069497923 @default.
• W2987524194 hasAuthorship W2987524194A5069915515 @default.
• W2987524194 hasAuthorship W2987524194A5071543379 @default.
• W2987524194 hasAuthorship W2987524194A5084257557 @default.
• W2987524194 hasAuthorship W2987524194A5085649748 @default.
• W2987524194 hasConcept C104317684 @default.
• W2987524194 hasConcept C11957725 @default.
• W2987524194 hasConcept C121608353 @default.
• W2987524194 hasConcept C142724271 @default.
• W2987524194 hasConcept C147447768 @default.
• W2987524194 hasConcept C173396325 @default.
• W2987524194 hasConcept C190283241 @default.
• W2987524194 hasConcept C203014093 @default.
• W2987524194 hasConcept C204232928 @default.
• W2987524194 hasConcept C2776415932 @default.
• W2987524194 hasConcept C2779013556 @default.
• W2987524194 hasConcept C502942594 @default.
• W2987524194 hasConcept C54009773 @default.
• W2987524194 hasConcept C54355233 @default.
• W2987524194 hasConcept C55493867 @default.
• W2987524194 hasConcept C555283112 @default.
• W2987524194 hasConcept C71924100 @default.
• W2987524194 hasConcept C76419328 @default.
• W2987524194 hasConcept C81885089 @default.
• W2987524194 hasConcept C86803240 @default.
• W2987524194 hasConceptScore W2987524194C104317684 @default.
• W2987524194 hasConceptScore W2987524194C11957725 @default.
• W2987524194 hasConceptScore W2987524194C121608353 @default.
• W2987524194 hasConceptScore W2987524194C142724271 @default.
• W2987524194 hasConceptScore W2987524194C147447768 @default.
• W2987524194 hasConceptScore W2987524194C173396325 @default.
• W2987524194 hasConceptScore W2987524194C190283241 @default.
• W2987524194 hasConceptScore W2987524194C203014093 @default.
• W2987524194 hasConceptScore W2987524194C204232928 @default.
• W2987524194 hasConceptScore W2987524194C2776415932 @default.
• W2987524194 hasConceptScore W2987524194C2779013556 @default.
• W2987524194 hasConceptScore W2987524194C502942594 @default.
• W2987524194 hasConceptScore W2987524194C54009773 @default.
• W2987524194 hasConceptScore W2987524194C54355233 @default.
• W2987524194 hasConceptScore W2987524194C55493867 @default.
• W2987524194 hasConceptScore W2987524194C555283112 @default.
• W2987524194 hasConceptScore W2987524194C71924100 @default.
• W2987524194 hasConceptScore W2987524194C76419328 @default.
• W2987524194 hasConceptScore W2987524194C81885089 @default.
• W2987524194 hasConceptScore W2987524194C86803240 @default.
• W2987524194 hasFunder F4320313614 @default.

• next